Demax Medical Technology

At Demax, we focus on the R&D and production of Disposable Interventional Therapy products for the cardiovascular system. Demax Group established in 2004, consists of Australia Demax Medical, Beijing Demax Medical, and Tianjin Demax Medical.
Until now, Demax has established long-term collaboration relations with customers and medical institutions from more than 70 countries; our products are distributing worldwide. In China, on average, about 3 out of 10 have enjoyed the services provided by Demx among the 300 million cardiovascular patients.
Through tireless efforts, Demax has successively obtained the approval and protection of Madrid International Registration of Marks from 2011 to 2014 in 9 countries, including South Korea, the United States, Turkey, Switzerland, Syria, Australia, the European Union, Iran, and Egypt.